Picture of Dr. Jeffrey  Chen

Dr. Jeffrey Chen BSc, PhD Research Scientist VIDO-InterVac

Research Area(s)

  • Mycobacterial virulence factors, TB host-pathogen interactions, TB vaccine and drug development, TB animal modeling, TB aerobiology


Dr. Chen received a BSc (Hons) in marine biology and biochemistry from Dalhousie University, and a PhD in molecular genetics and microbiology from the University of Toronto. He was a Canadian Lung Association and the Canadian Institutes of Health Research post-doctoral fellow at the École Polytechnique Fédérale de Lausanne, Global Health Institute in Switzerland.

His research is presently focused on the following areas:
1.      Understanding the role of the multi-component type-7 secretion system ESX-1 in TB host-pathogen interactions (NSERC-funded)
2.      Developing the next generation of live BCG vaccines for TB (National Sanitarium Association & US DoD-funded)
3.      Developing a porcine model of TB infection and transmission (Saskatchewan Health Research Foundation & National Sanitarium Association-funded)
4.      Harnessing BCG-mediated trained immunity as an alternative to broad-spectrum antibiotics and antivirals for humans and livestock (Alberta Forestry & Agriculture-funded)